image
Supernus Pharmaceuticals, Inc. SUPN
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 32.43
0.123 %
$ 1.82 B
Market Cap
24.57
P/E
BALANCE SHEET
1.37 B ASSETS
7.08%
Growth Rates
1Year 7.08%
3Years -6.79%
5Years 3.35%
7Years 18.20%
10Years 25.83%
332 M LIABILITIES
-6.69%
Growth Rates
1Year -6.69%
3Years -27.53%
5Years -10.06%
7Years 11.31%
10Years 17.52%
1.04 B EQUITY
12.39%
Growth Rates
1Year 12.39%
3Years 8.28%
5Years 11.71%
7Years 21.34%
10Years 30.67%
BALANCE SHEET DECOMPOSITION
Balance Sheet Supernus Pharmaceuticals, Inc.
image
Current Assets 686 M
Cash & Short-Term Investments 454 M
Receivables 142 M
Other Current Assets 90.4 M
Non-Current Assets 682 M
Long-Term Investments 0
PP&E 11.5 M
Other Non-Current Assets 670 M
33.16 %10.39 %6.61 %49.01 %Total Assets$1.4b
Current Liabilities 292 M
Accounts Payable 4.59 M
Short-Term Debt 0
Other Current Liabilities 288 M
Non-Current Liabilities 39.9 M
Long-Term Debt 0
Other Non-Current Liabilities 39.9 M
86.60 %12.02 %Total Liabilities$332.3m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008
ASSETS
Cash & Cash Equivalents 69.3 75.1 93.1 203.4 288.6 181.4 192.2 100.3 90.1 62.2 74.3 82.2 88.5 48.5 23.7 31.4 52.9
Short Term Investments 384.3 179.8 368.2 136.2 133.9 165.7 163.8 39.7 23.7 28.0 37.9 49.2 48.2 0 9.0 35.1 7.5
Receivables 142.1 144.2 165.5 148.9 140.9 87.3 102.9 65.6 41.5 25.9 17.3 5.1 0.7 0 0.2 3.7 2.3
Inventory 54.3 77.4 91.5 86.0 48.3 26.6 25.7 16.3 16.8 12.6 13.4 7.2 1.2 0.4 6.8 2.3 6.5
Other Current Assets 36.1 16.7 15.8 54.0 37.4 23.2 17.8 13.0 5.9 5.3 7.5 2.8 1.1 0.5 7.0 0.3 0.3
Total Current Assets 686.1 493.1 734.2 601.6 630.4 472.6 493.5 228.5 151.4 106.0 108.9 97.2 91.7 49.4 39.8 72.9 69.5
PP&E 11.5 42.5 15.2 17.0 37.8 38.3 4.1 5.1 4.3 3.9 2.4 2.6 1.4 1.3 1.2 1.9 2.0
Intangible Assets 521.9 599.9 702.5 784.7 442.3 24.8 31.4 36.0 16.5 1.0 5.4 1.2 0.7 0.9 1.1 1.4 1.6
Goodwill 117.0 117.0 117.0 117.5 77.9 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 16.6 93.9 119.2 350.4 591.8 418.8 133.6 75.4 55.0 19.8 8.8 0 0 0 0 0
Other Long Term Assets 31.5 8.5 (10.0) (36.1) 8.0 0.6 0.4 0.4 20.2 0.4 6.4 1.5 0.1 2.1 4.8 3.8 4.1
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 368.1 1 277.7 1 702.5 1 689.2 1 504.1 1 160.3 977.8 424.5 309.6 188.7 137.5 111.0 94.0 53.7 47.0 79.9 77.1
LIABILITIES
Accounts Payable 4.6 2.0 10.5 9.3 6.1 10.1 3.2 6.8 8.1 4.3 1.9 3.1 2.8 10.1 11.3 6.2 4.5
Short Term Debt 0 8.3 408.8 13.7 12.8 6.1 2.2 4.3 0 (17.1) 0 0 11.8 8.2 0 0 0
Other Current Liabilities 287.8 279.9 268.7 292.3 226.1 141.9 143.6 95.6 72.5 51.9 25.5 15.2 7.9 1.7 3.9 3.8 3.8
Total Current Liabilities 292.4 290.2 688.0 315.4 245.1 160.6 161.4 123.0 80.7 56.1 27.5 26.4 23.0 18.8 15.2 10.0 8.3
Long Term Debt 0 33.2 36.0 420.6 424.0 375.6 329.5 22.3 4.2 7.1 26.9 34.4 11.1 21.8 75.0 75.0 75.0
Deferred Tax Income 5.0 25.0 49.8 85.4 35.2 37.3 31.5 15.0 0.1 0.9 6.6 12.6 (0.3) 0.9 0 0 (75.0)
Other Liabilities 35.0 7.8 42.5 52.0 90.2 28.7 34.0 10.6 31.4 35.2 10.4 15.3 2.0 1.4 1.1 1.0 0.2
Total Liabilities 332.3 356.2 816.3 873.3 759.2 564.9 524.8 157.0 117.8 69.9 66.2 77.5 36.4 44.3 91.3 86.1 83.9
EQUITY
Common Stock 56 K 55 K 54 K 53 K 53 K 53 K 52 K 51 K 50 K 49 K 43 K 40 K 31 K 14 K 2 K 6 K 5.52 K
Retained Earnings 556.4 482.6 481.2 379.9 326.5 199.5 86.5 (26.8) (84.3) (144.6) (158.7) (178.5) (86.3) (40.0) (93.8) (55.3) (55.8)
Other Accumulative Comprehensive Income/Loss (0.2) (0.6) (3.2) 1.5 9.0 7.4 (3.2) (0.7) (0.1) (0.5) (0.2) 0 57 K 1 K 0 2 K (2.1)
Total Equity 1 035.7 921.5 886.2 815.9 744.9 595.4 453.0 267.5 191.8 118.9 71.4 33.5 57.6 9.4 (44.3) (6.2) (6.7)
Total Liabilities and Equity 1 368.1 1 277.7 1 702.5 1 689.2 1 504.1 1 160.3 977.8 424.5 309.6 188.7 137.5 111.0 94.0 53.7 47.0 79.9 77.1
SHARES OUTSTANDING
Common Shares Outstanding 55.1 54.5 53.7 53.1 52.6 52.4 52.0 50.8 49.5 47.5 42.3 31.8 17.4 13.9 13.9 13.9 13.9 13.9